{
  "ptid_time": "130_S_2373_2013-05-14",
  "img_path": "/data/qiuhui/data/adni/images/130_S_2373/2013-05-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 20,226 mm³, 45.3% below the reference mean. With a Z-score of -1.22 (11.1th percentile), this represents mild atrophy; hippocampal volume measures 4,442 mm³, 31.6% below the reference mean. With a Z-score of -2.53 (0.6th percentile), this represents significant atrophy; whole brain volume measures 843,624 mm³, 9.1% below the reference mean. With a Z-score of -1.09 (13.7th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,652 mm³, 5.5% above the reference mean. With a Z-score of 0.30 (61.6th percentile), this represents normal volume ; fusiform gyrus volume measures 14,614 mm³, 9.3% below the reference mean. With a Z-score of -0.70 (24.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,362 mm³, 14.8% below the reference mean. With a Z-score of -1.32 (9.4th percentile), this represents mild atrophy. ",
  "text_data": "Age is 81.0 years. Gender is Female. Education: 13 years. MMSE: 25.0. MoCA: 19.0. Logical Memory: 10.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.26 SUVR (mild elevated); Amyloid beta: 572.30 pg/mL (mild reduced); Total tau: 431.80 pg/mL (significant elevated); Phosphorylated tau: 44.26 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient exhibits significant hippocampal atrophy (Z-score -2.53, 0.6th percentile) and mild atrophy in other regions (ventricular, whole brain, middle temporal gyrus), alongside biomarker evidence of amyloid pathology (mildly reduced Aβ, elevated T-tau/P-tau, and AV45). Cognitive testing (MMSE 25, MoCA 19) suggests mild impairment, consistent with MCI. APOE4 positivity and age further support neurodegenerative pathology.  \n\n**Diagnosis:** **MCI** (likely prodromal Alzheimer’s given biomarker profile).  \n**Confidence:** **High** (convergence of structural atrophy, biomarker abnormalities, and cognitive scores).  \n\n*Note: Progression to dementia is likely given the severity of hippocampal atrophy and tau elevation, but current cognitive deficits align more closely with MCI thresholds.*",
  "timestamp": "2025-07-26T14:36:45.139002"
}